Page 65 - Read Online

Page 18 of 20 Jiang et al. Microbiome Res Rep 2024;3:47 https://dx.doi.org/10.20517/mrr.2024.12

39. Zhang L, Ji Q, Chen Q, et al. Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to
counter the progression of colorectal cancer. Int J Biol Sci 2023;19:4393-410. DOI PubMed PMC
40. Meng X, Zhang J, Wu H, Yu D, Fang X. Akkermansia muciniphila aspartic protease Amuc_1434* inhibits human colorectal cancer
LS174T cell viability via TRAIL-mediated apoptosis pathway. Int J Mol Sci 2020;21:3385. DOI PubMed PMC
41. Tong Q, Li K, Huang F, et al. Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy.
Mater Today Bio 2023;23:100845. DOI PubMed PMC
42. Rigsbee L, Agans R, Shankar V, et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel
syndrome. Am J Gastroenterol 2012;107:1740-51. DOI PubMed
43. Chen Y, Xiao S, Gong Z, et al. Wuji Wan Formula ameliorates diarrhea and disordered colonic motility in post-inflammation irritable
bowel syndrome rats by modulating the gut microbiota. Front Microbiol 2017;8:2307. DOI PubMed PMC
44. Huang HL, Chen HT, Luo QL, et al. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes
in diversity and composition of the gut microbiota. J Dig Dis 2019;20:401-8. DOI PubMed
45. Cruz-Aguliar RM, Wantia N, Clavel T, et al. An open-labeled study on fecal microbiota transfer in irritable bowel syndrome patients
reveals improvement in abdominal pain associated with the relative abundance of Akkermansia Muciniphila. Digestion
2019;100:127-38. DOI PubMed
46. Liu MJ, Yang JY, Yan ZH, et al. Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases.
Clin Nutr 2022;41:2333-44. DOI PubMed
47. Sundin J, Rangel I, Repsilber D, Brummer RJ. Cytokine response after stimulation with key commensal bacteria differ in post-
infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controls. PLoS One 2015;10:e0134836. DOI PubMed
PMC
48. Dorofeyev A, Dorofeyeva A, Borysov A, Tolstanova G, Borisova T. Gastrointestinal health: changes of intestinal mucosa and
microbiota in patients with ulcerative colitis and irritable bowel syndrome from PM -polluted regions of Ukraine. Environ Sci Pollut
2.5
Res Int 2023;30:7312-24. DOI PubMed
49. Lo Presti A, Del Chierico F, Altomare A, et al. Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in
IBD and IBS. Future Microbiol 2019;14:1497-509. DOI PubMed
50. Lopez-Siles M, Enrich-Capó N, Aldeguer X, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and
Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front Cell Infect Microbiol 2018;8:281.
DOI PubMed PMC
51. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism
involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103. DOI PubMed PMC
52. Dao MC, Everard A, Aron-Wisnewsky J, et al; MICRO-Obes Consortium. Akkermansia muciniphila and improved metabolic health
during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 2016;65:426-36. DOI PubMed
53. Hänninen A, Toivonen R, Pöysti S, et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet
autoimmunity in NOD mice. Gut 2018;67:1445-53. DOI PubMed
54. Kihl P, Krych L, Deng L, et al. Oral LPS dosing induces local immunological changes in the pancreatic lymph nodes in mice. J
Diabetes Res 2019;2019:1649279. DOI PubMed PMC
55. Guimarães JB, Rodrigues VF, Pereira ÍS, et al. Inulin prebiotic ameliorates type 1 diabetes dictating regulatory T cell homing via
CCR4 to pancreatic islets and butyrogenic gut microbiota in murine model. J Leukoc Biol 2024;115:483-96. DOI PubMed
56. Zhang J, Ni Y, Qian L, et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and
glucose homeostasis in lean type 2 diabetes. Adv Sci 2021;8:e2100536. DOI PubMed PMC
57. Chelakkot C, Choi Y, Kim DK, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the
regulation of tight junctions. Exp Mol Med 2018;50:e450. DOI PubMed PMC
58. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced
obesity. Proc Natl Acad Sci U S A 2013;110:9066-71. DOI PubMed PMC
59. Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced
by house-dust mite. Pediatr Allergy Immunol 2005;16:433-8. DOI PubMed
60. Sakai T, Taki T, Nakamoto A, et al. Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat
diet. J Nutr Sci Vitaminol 2013;59:144-7. DOI PubMed
61. Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose
homeostasis in diet-induced obese mice. Gut 2014;63:727-35. DOI PubMed
62. Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 2014;80:5935-43. DOI
PubMed PMC
63. Santacruz A, Collado MC, García-Valdés L, et al. Gut microbiota composition is associated with body weight, weight gain and
biochemical parameters in pregnant women. Br J Nutr 2010;104:83-92. DOI PubMed
64. Forslund K, Hildebrand F, Nielsen T, et al; MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures
in the human gut microbiota. Nature 2015;528:262-6. DOI PubMed PMC
65. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human
volunteers: a proof-of-concept exploratory study. Nat Med 2019;25:1096-103. DOI PubMed PMC
66. Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol 2013;59:583-94. DOI